ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_35893_2 # 427 # 1161 # -1 # ID=25_2;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.263	k141_35893_2	427	1161	-	Strict	400	488.804	ErmG	98.36	3000522	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACAAAGTAAATATAAAAGATAGTCAAAATTTTATTACTTCAAAATATCACATAGAAAAAATAATGAATTGCATAAGTTTAGATGAAAAAGATAACATCTTTGAAATAGGTGCAGGGAAAGGTCATTTTACTGCTGAATTGGTAAAGAGATGTAATTTTGTTACGGCGATAGAAATTGATTCTAAATTATGTGAGGTAACTCGTAATAAGCTCTTAAATTATCCTAACTATCAAATAGTAAATGATGATATACTAAAATTTACATTTCCTAGCCACAATCCATATAAAATATTTGGCAACATACCTTACAACATAAGCACAAATATAATTCGAAAAATTGTTTTTGAAAGTTCAGCCACAATAAGTTATTTAATAGTGGAATATGGTTTTGCTAAAATGTTATTAGATACAAACAGATCACTAGCATTGCTGTTAATGGCAGAGGTAGATATTTCTATATTAGCAAAAATTCCCAGGTATTATTTCCATCCAAAACCTAAAGTGGATAGCGCATTAATTGTATTAAAAAGAAAGCCAGCAAAAATGGCATTTAAAGAGAGAAAAAAACATGAAACTTTTGTAATGAAATGGGTTAACAAAGAGTATGAAAAACTGTTTACAAAAAATCAATTTAATAAAGCTTTAAAATATGCGAGAATATATGATATAAACAATATTAGTTTCGAACAATTTGTATCGCTATTTAATAGTTATAAAATATTTAACGGCTAA	MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGNIPYNISTNIIRKIVFESSATISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSALIVLKRKPAKMAFKERKKHETFVMKWVNKEYEKLFTKNQFNKALKYARIYDINNISFEQFVSLFNSYKIFNG	MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSATISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSTLIVLKRKPAKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYKIFNG	100.00	gnl|BL_ORD_ID|935|hsp_num:0	989		
k141_15339_89 # 123489 # 126635 # -1 # ID=31_89;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.455	k141_15339_89	123489	126635	-	Strict	750	795.808	adeF	43.39	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTTTCTAAGTTTTTCATTAACCGACCAATTTTTGCTACCGTACTTGCCCTGCTCATTGTGGTAGCCGGTTTGGTCGCACTCAATATATTGCCTGTGGCGCAATTTCCGGAGATTACACCTCCGACGGTTCAGGTATCGGCTGTCTATCCCGGTGCGAATGCTGAAACTGTAGCCCAAACGGTAGGGCTCCCCATCGAACAGCAGGTGAATGGGGTGGACGGTATGCTCTATATGTCTTCAAATTCTTCTTCTTCAGGAGCATATTCGCTGACAATTACATTTGCCGTCGGTACAGATATCGATATGGCTACCGTACAAGTACAGAACAGGGTAAGTGTTGCGCAATCATCCTTGCCGGAACCGGTAGTGGTGCAGGGGGTAACTGTGCAGAAACAGTCTTCGAACATTGTCATGTTCCTGACAATGACTTCGAAAGACTCCGTCTACAACAGTCTCTATCTGACTAACTATGCCAAATTGAATTTGGTCGATCAGTTATCACGTGTGCCTGGCGTAGGAGCTGTTAATGTCATGGGAGCAGGTGATTATTCCATGCGTATCTGGCTGGACCCTGAAGCCATGCGTATCCGGAACATTTCTCCGGCACAAGTATATCAGTCTATTCAGTCTCAGAATATGGAAGTGTCCGCCGGCTATATCGGTCAACCGATCGGACAGGACAATAAAAATGCCTTTCAATATACACTTAATGTGCAGGGGCGACTTACTTCTCCGGAGCAATTCGGGAATATTATCATTCGTCGGGAACAGGATGGGGCAATGCTTCGCCTGAAGGATATTGCGCAAATAGATTTGGGGTCTGCTTCTTATAGTGTAGTATCACGATTGAAGGGGATGCCTACCGCAGCGATTGCTATCTATCAGCAGCCGGGTTCCAATTCGCTGGACGTTTCAAAGGGGGTGAAGGCTAAGATGGAGGAACTGGCGACCAGTTTTCCTACAGGAGTAGCCTATAACGTAACTTTGGATACAACGGATGTAATTCATGCTTCTATTGATGAAGTAATGGTGACATTTTTTGAGACAACGCTGCTGGTAGTACTGGTTATTTTCCTGTTTTTGCAGAACTGGAGAGCGGTTATTATTCCTTGTATCACAATTCCTGTATCGCTGATCGGTACATTGGCAGTTATGGCGGCATTTGGTTTTTCGATCAATACGCTGACTCTGTTCGGATTGATTCTGGCAGTTGCCATTGTGGTGGATGATGCTATTGTGGTGGTTGAGAACGCTTCGAGATTGTTGGAAACCGGACAATATTCAACTCGTGAAGCAGTCACGAAAGCTATGGGGGAAATTACGGGGCCGATTGTCGGAGTGGTGCTTGTTTTGCTTGCCGTGTTTATTCCGACAATGATGATCAGCGGTATTTCGGGACAGTTGTATAAGCAGTTTGCACTGACAATTGCTGCTTCTACCGTATTAAGCGGTTTTAACTCACTGACACTGACGCCTGCTCTTTGTGCTCTATTCCTCGAAAAGAGCAAACCGTCTAACTTCTTTATATACAAAGGATTTAATAAAGCGTATGATAAGACGCAGGGAGTCTACGATAGTACGGTAAAATGGTTGCTTCAACGTCCGCTTATCTCTTTTGTATCTTTTGCTATTCTGACAGTGATTGCCGTAATACTCTTTATGCGTTGGCCGTCGACATTTATTCCGGATGAAGATGATGGTTATTTTATTGCTGTTGTTCAGCTTCCTCCGGCAGCCAGCCTGGAGCGTACACAAGCTGTCGGAGATAAAATCAATGCTATTTTGGATTCTTATCCGGAAGTGGAGAATTACATTGGAATCACTGGTTTCTCCGTGATGGGCGGAGGTGAGCAAAGTAACTCCGCAACCTATTTTGTTGTCTTGAAAAACTGGGACGAAAGGAAAGGGAAGGAGCATACGGCTGCTGCCGTTGTCGACCGTTTTAATGGCGAAGCGTATATGGAGATACAAGCGGGGCAGGCATTTGCTATGGTTCCTCCGGCTATTCCCGGATTGGGTGCTTCCGGTGGCTTGCAACTTCAATTGGAAGACCGGAGAAATCTGGGACCGACAGAAATGCAGCAGGCTATTGACGCATTGCTTGCTTCTTCTCATTCCAAACCGGCCTTAGCTTCTGTATCCAGTCAGTATCAGGCAAATGTCCCGCAATATTTTCTGAATATCGACCGTGATAAGGTGCAATTTATGGGCATTGCTCTGAATGATGTATTTTCTACATTAAGCTACTATATGGGGGCGGCATACGTTAATGATTTTGTTGAATTCGGTCATATTTATCAGGTAAAGATCGAAGCGCGTGATCAGGCACAACGAGTCATTGATGATGTTTTAAAACTCAGTGTGGCGAACTCGGCAGGAGAGATGGTCCCCCTTTCTTCTTTCACCAAAGTGGAAGAGCAGTTGGGGCAGGATCAGATCAATCGTTACAATATGTATTCAACAGCTGCCCTGACTTGTAATGTAGCGCCCGGAAGCAGTTCCGGACAGGCTATTCAAGAAATAGAAACTTTGTTTAAAGAACAGCTGGGAGATGAATTTGGCTATGAATGGACGTCAGTTGCCTATCAGGAAACGCAGGCGGGAAATACGACCACCATTGTTCTGGTCATGGCCTTGATTGTGGCATTCCTTGTTTTGGCTGCGCAATATGAAAGCTGGACCAGTCCGGTGGCTGCCGTGATAGGTTTGCCGGTGGCCTTGTTGGGAGCAATGATAGGATGTATGATAATGGGAACTCCGGTCAGCGTATATACACAAATTGGTATTATCCTGCTTGTTGCACTTTCGGCAAAGAATGGTATTCTGATTGTAGAGTTTGCCCGTGATTTCCGTGCTGAAGGAAACTCAATTCGTGAGGCTGCATACGAAGCAGGACACGTCCGCTTACGTCCGATTTTGATGACTTCTTTTGCTTTTGTATTGGGAGTAATGCCTTTGCTGTTTGCTACCGGAGCTGGTGCACAGAGCCGTATAGCGTTGGGTACTGCGGTTGTTTTCGGTATGGCGATGAATACTTTATTAGCGACAGTCTATATTCCTAATTTCTATGAATTGATGCAGAAACTGCAAGAGAAGTTTAGCAGGAAGAAAAATGATGATGTGAAAAAAAATACGGATATGTAA	MFSKFFINRPIFATVLALLIVVAGLVALNILPVAQFPEITPPTVQVSAVYPGANAETVAQTVGLPIEQQVNGVDGMLYMSSNSSSSGAYSLTITFAVGTDIDMATVQVQNRVSVAQSSLPEPVVVQGVTVQKQSSNIVMFLTMTSKDSVYNSLYLTNYAKLNLVDQLSRVPGVGAVNVMGAGDYSMRIWLDPEAMRIRNISPAQVYQSIQSQNMEVSAGYIGQPIGQDNKNAFQYTLNVQGRLTSPEQFGNIIIRREQDGAMLRLKDIAQIDLGSASYSVVSRLKGMPTAAIAIYQQPGSNSLDVSKGVKAKMEELATSFPTGVAYNVTLDTTDVIHASIDEVMVTFFETTLLVVLVIFLFLQNWRAVIIPCITIPVSLIGTLAVMAAFGFSINTLTLFGLILAVAIVVDDAIVVVENASRLLETGQYSTREAVTKAMGEITGPIVGVVLVLLAVFIPTMMISGISGQLYKQFALTIAASTVLSGFNSLTLTPALCALFLEKSKPSNFFIYKGFNKAYDKTQGVYDSTVKWLLQRPLISFVSFAILTVIAVILFMRWPSTFIPDEDDGYFIAVVQLPPAASLERTQAVGDKINAILDSYPEVENYIGITGFSVMGGGEQSNSATYFVVLKNWDERKGKEHTAAAVVDRFNGEAYMEIQAGQAFAMVPPAIPGLGASGGLQLQLEDRRNLGPTEMQQAIDALLASSHSKPALASVSSQYQANVPQYFLNIDRDKVQFMGIALNDVFSTLSYYMGAAYVNDFVEFGHIYQVKIEARDQAQRVIDDVLKLSVANSAGEMVPLSSFTKVEEQLGQDQINRYNMYSTAALTCNVAPGSSSGQAIQEIETLFKEQLGDEFGYEWTSVAYQETQAGNTTTIVLVMALIVAFLVLAAQYESWTSPVAAVIGLPVALLGAMIGCMIMGTPVSVYTQIGIILLVALSAKNGILIVEFARDFRAEGNSIREAAYEAGHVRLRPILMTSFAFVLGVMPLLFATGAGAQSRIALGTAVVFGMAMNTLLATVYIPNFYELMQKLQEKFSRKKNDDVKKNTDM	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	98.96	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_25634_41 # 71137 # 74241 # 1 # ID=80_41;partial=00;start_type=ATG;rbs_motif=AATAA;rbs_spacer=3bp;gc_cont=0.462	k141_25634_41	71137	74241	+	Strict	750	780.785	adeF	42.83	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTTAGTTTTTTTATAGACAGGCCGGTATTTTCGGCTGTCATTTCCATCGTGATTGTGATTGTCGGAGTCATCGGGCTGACCATGCTTCCGGTGGATCAATATCCGCAGATCACGCCTCCGGTGGTAAAGATCAGTGCGTCTTATCCGGGTGCGAGTGCGCTTACCGTGTCGCAGGCGGTGGCTACTCCGATTGAACAGGAAATCAATGGTACGCCCGGTATGCTTTATATGGAATCGAACAGTTCTAACTCTGGTGGCTTCTCGGCAACAGTTACCTTTGATGTATCTGCCGACCCGGATCTGGCTGCTGTGGAAATTCAGAACCGTGTGAAGCTGGCTGAATCCCGTCTTCCGGCGGAAGTGATTCAGAATGGTATTTCCGTAGAGAAACAGGCACCCAGTCAGTTAATGACACTCTGTCTGACTTCTACCGATCCTAAGTTTGACGAAATTTACCTGAGCAACTTTGCTACGATCAATGTGCTCGATGTGATTCGCCGTATTCCGGGGGTAGGACGTGTATCTAATATCGGTAGCCGTTACTATGCCATGCAGATATGGGCAGAGCCTGATAAGCTGGCTAACTTCGGATTGACTGTGCAGGACTTGCAGAATGCCTTGAAAGATCAGAACCGTGAATCGGCAGCCGGTGTATTAGGTCAGCAGCCGGTACAGGGACTGGATATAACGATTCCTATCACTACTCAGGGACGTCTTTCTACAGTAGGGCAATTTGAGGATATTGTGGTACGTGCCAATGCCAATGGTTCCATCATCCGGCTGAAGGATGTGGCACGTGTATCCTTGGAGGCTTCTTCATACAATACCGAGAGTGGTATCAATGGTGAGAATGCAGCGGTACTCGGTATTTACATGTTGCCGGGTGCCAATGCAATGGAAGTGGCCGAGAATGTAAAGAAGGCGATGGAAGAAATCAGCGAGAATTTTCCGGAAGGATTGAGTTATGAGATTCCGTTTGATATGACAACGTATATCTCCGAGTCTATTCATGAGGTATATAAGACCTTGTTTGAAGCATTGGTGCTGGTTGTGTTGGTAGTGTATCTGTCTTTGCAGAGCTGGCGTGCTACGTTGATTCCGGTGGTAGCGGTACCTATTTCCCTGATTGGTACTTTCGGATTCATGCTGATTTTTGGTTTCTCTATTAATATATTGACCTTACTCGGGTTGATTCTCGCCATCGGTATCGTGGTCGATGATGCGATTGTAGTGGTGGAAGGAGTGGAGCATATAATGGAAACGGAGAAGCTGAGTCCCTATGAGGCGACAAAGAAAGCGATGAACGGATTATCAAGCGCATTGATCGCTACTTCACTGGTATTGGCGGCTGTGTTTGTTCCGGTAAGTTTTCTGAGTGGAATTACCGGGCAACTGTATCGTCAGTTTACGGTAACTATCGTGGTATCTGTACTGATTTCTACTGTGGTTGCTTTAACGCTGAGCCCTGTGATGTGTTCGCTCATTTTGAAACCAGATAGTGGCAAGAAGAAAAATATAGTATTCAGAAAGATCAATGAGTGGCTGGGTATCGGAAGCAATAAGTATGTAGCTGCCGTCACCCGTACTATCAAACATCCTCGTCGGGTTTTGAGTGCTTTTGGTATGGTATTGATTGCTATTCTGTTGATTCACCGGATTATTCCGACCAGTTTCTTGCCGGTAGAAGACCAAGGATACTTTAAGATTGAACTTGAACTGCCGGAAGGAGCTACATTGGAGCGAACCCGTGTAGTAACGGAACGCGCGATTGCTTATCTGGAGAAGAATCCATATATAGAATATGTACAAAACGTGACCGGAAGCAGCCCGCGTGTAGGGAGTAATCAGGGGCGTGCCGAGCTGACCGTTATTCTGAAACCTTGGGAAGAGAGAAAGAGCACCAGTATTGAAAAAATTATGGATACGGTAGAAAAACATTTGAGAGAATATCCCGAATGTAAAGTCTACCTGTCTACTCCTCCGGTCATACCGGGACTGGGTAGTTCCGGTGGTTTTGAAATGCAGCTGGAAGCTCGTGGAGAGGCTACTTTCGATAATTTGGTAGATGCGGCAGATACGTTGATGTATTATGCTTCGAAACGTAAGGAACTTACCGGTTTGTCTTCTTCCTTGCAGTCTGAGATTCCCCAGCTTTATTTTGATGTGGACAGAGACAAAGTGAAAATGCTGGGAGTACCTTTGGCAGATGTGTTTTCTACGATGAAAGCGTATACAGGTTCGGTGTATGTGAATGACTTTAATATGTTCAACCGTATATATAAGGTGTATATTCAGGCGGAGGCTCCTTATCGGGAACATAAAGACAATATCAACCTGTTCTTTGTGAAAGCTTCTAACGGAGCTATGGTACCGTTGACTTCTTTGGGTAATGCCTCTTATACAACAGGACCGGGAAGTATCAAGCGTTTCAATATGTTTACTACTGCCGTTATCCGGGGTGCTGCCGCACAGGGATACAGTTCCGGTCAGGCAATGGAGATTATGGAGCAGATCGCCCGTGACCATCTTCCGGATAATATCGGACTGGAGTGGAGCGGACTTTCTTATCAGGAGAAACAGGCAGGCGGTCAGACAGGTATGGTCATGGCATTGGTGTTCTTGTTCGTCTTCCTTTTCCTTGCCGCACAATATGAAAGTTGGACAGTGCCGATTGCTGTATTGCTATCTTTGCCTGTAGCAGCTTTGGGAGCCTATCTGGGAGTCTGGGTATGCGGACTGGAGAATGATGTCTATTTCCAGATCGGATTGGTAATGCTTGTCGGGCTTGCCGCCAAGAATGCCATTTTGATTGTTGAGTTTGCCAAAGTGCAGGTAGATAAAGGTGAAGACTTGATACAGTCGGCAATCTATGCAGCGAAATTACGTTTCCGTCCTATTCTGATGACCTCCCTTGCGTTTGTATTGGGAATGCTTCCGATGGTATTGGCGAGTGGTCCGGGTTCGGCTAGCCGACAGGCGATTGGTACGGGCGTATTCTTCGGAATGATATTCGCTATCGTATTTGGTATCATTCTCGTGCCGTTCTTCTTTGTGATGGTGTATAAAACAAAGTCGAAAATCTTAAAACATAAGAAATAA	MKVSFFIDRPVFSAVISIVIVIVGVIGLTMLPVDQYPQITPPVVKISASYPGASALTVSQAVATPIEQEINGTPGMLYMESNSSNSGGFSATVTFDVSADPDLAAVEIQNRVKLAESRLPAEVIQNGISVEKQAPSQLMTLCLTSTDPKFDEIYLSNFATINVLDVIRRIPGVGRVSNIGSRYYAMQIWAEPDKLANFGLTVQDLQNALKDQNRESAAGVLGQQPVQGLDITIPITTQGRLSTVGQFEDIVVRANANGSIIRLKDVARVSLEASSYNTESGINGENAAVLGIYMLPGANAMEVAENVKKAMEEISENFPEGLSYEIPFDMTTYISESIHEVYKTLFEALVLVVLVVYLSLQSWRATLIPVVAVPISLIGTFGFMLIFGFSINILTLLGLILAIGIVVDDAIVVVEGVEHIMETEKLSPYEATKKAMNGLSSALIATSLVLAAVFVPVSFLSGITGQLYRQFTVTIVVSVLISTVVALTLSPVMCSLILKPDSGKKKNIVFRKINEWLGIGSNKYVAAVTRTIKHPRRVLSAFGMVLIAILLIHRIIPTSFLPVEDQGYFKIELELPEGATLERTRVVTERAIAYLEKNPYIEYVQNVTGSSPRVGSNQGRAELTVILKPWEERKSTSIEKIMDTVEKHLREYPECKVYLSTPPVIPGLGSSGGFEMQLEARGEATFDNLVDAADTLMYYASKRKELTGLSSSLQSEIPQLYFDVDRDKVKMLGVPLADVFSTMKAYTGSVYVNDFNMFNRIYKVYIQAEAPYREHKDNINLFFVKASNGAMVPLTSLGNASYTTGPGSIKRFNMFTTAVIRGAAAQGYSSGQAMEIMEQIARDHLPDNIGLEWSGLSYQEKQAGGQTGMVMALVFLFVFLFLAAQYESWTVPIAVLLSLPVAALGAYLGVWVCGLENDVYFQIGLVMLVGLAAKNAILIVEFAKVQVDKGEDLIQSAIYAAKLRFRPILMTSLAFVLGMLPMVLASGPGSASRQAIGTGVFFGMIFAIVFGIILVPFFFVMVYKTKSKILKHKK	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.64	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_25636_69 # 106923 # 107075 # 1 # ID=82_69;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=11bp;gc_cont=0.379	k141_25636_69 	106923	107075	+	Strict	500	21.557	ACT-38	100.0	3003655	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGGCTTGTTTTATTTTAATCATTATGCTGATTGATAGCGGAATGAGAGTATTTAAACCGTTAAAGAAACAGGAGCAAAAGTTCCTTTTTAACGCTCTTTTATGGAAGTCCGTTCGTGGTGGTTCAGAGCCGGAATCGCCGTTATCTGAATAA	MACFILIIMLIDSGMRVFKPLKKQEQKFLFNALLWKSVRGGSEPESPLSE	MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANNPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWLGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAITMRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVKDMANWVMVNMKPDSLQDSSLKEGITLAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVEAAYRILDALQ	13.12	gnl|BL_ORD_ID|2105|hsp_num:0	3311	True	loose hit with at least 95 percent identity pushed strict
